A carregar...
Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation
Autologous, CCR5 gene-edited hematopoietic stem and progenitor cell (HSPC) transplantation is a promising strategy for achieving HIV remission. However, only a fraction of HSPCs can be edited ex vivo to provide protection against infection. To project the thresholds of CCR5-edition necessary for HIV...
Na minha lista:
| Publicado no: | eLife |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
eLife Sciences Publications, Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7803377/ https://ncbi.nlm.nih.gov/pubmed/33432929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.57646 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|